Xeris Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
Browse to the end of this webpage for potential risks for Xeris Pharmaceuticals Inc based on sector, location and marketcap. If you are employed by Xeris Pharmaceuticals Inc and you would like to licence your ESG aseessment, please get in touch. This webpage is a free Environmental, Social and Governance assessment covering Xeris Pharmaceuticals Inc.
Xeris Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.0; made up of an environmental score of 2.7, social score of 3.2 and governance score of 6.0.
4.0
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
989 | Spectrum Pharmaceuticals Inc | 4.1 | High |
989 | Tricida Inc | 4.1 | High |
1004 | Xeris Pharmaceuticals Inc | 4.0 | High |
1004 | Can B Corp | 4.0 | High |
1004 | CLS Holdings USA Inc | 4.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Xeris Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Does Xeris Pharmaceuticals Inc disclose current and historical energy intensity?
Does Xeris Pharmaceuticals Inc report the average age of the workforce?
Does Xeris Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Does Xeris Pharmaceuticals Inc disclose its ethnicity pay gap?
Does Xeris Pharmaceuticals Inc disclose cybersecurity risks?
Does Xeris Pharmaceuticals Inc offer flexible work?
Does Xeris Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Xeris Pharmaceuticals Inc disclose the number of employees in R&D functions?
Does Xeris Pharmaceuticals Inc conduct supply chain audits?
Does Xeris Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Xeris Pharmaceuticals Inc conduct 360 degree staff reviews?
Does Xeris Pharmaceuticals Inc disclose the individual responsible for D&I?
Does Xeris Pharmaceuticals Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Xeris Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Does Xeris Pharmaceuticals Inc disclose water use targets?
Does Xeris Pharmaceuticals Inc have careers partnerships with academic institutions?
Did Xeris Pharmaceuticals Inc have a product recall in the last two years?
Does Xeris Pharmaceuticals Inc disclose incidents of discrimination?
Does Xeris Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Has Xeris Pharmaceuticals Inc issued a profit warning in the past 24 months?
Does Xeris Pharmaceuticals Inc disclose parental leave metrics?
Does Xeris Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Does Xeris Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Xeris Pharmaceuticals Inc disclose the pay ratio of women to men?
Does Xeris Pharmaceuticals Inc support suppliers with sustainability related research and development?
Does Xeris Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Xeris Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Xeris Pharmaceuticals Inc involved in embryonic stem cell research?
Does Xeris Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Does Xeris Pharmaceuticals Inc disclose its waste policy?
Does Xeris Pharmaceuticals Inc report according to TCFD requirements?
Does Xeris Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Xeris Pharmaceuticals Inc disclose energy use targets?
Does Xeris Pharmaceuticals Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Xeris Pharmaceuticals Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Xeris Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.